Skip to content

Deltec 21-3257-24Recalls & reported problems

Icu Medical, Inc. · Class 2

All models of Deltec (97)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10610586029806), received between May 5, 2021 and May 21, 2026 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Difficult to Remove” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 1 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Difficult to Remove1
  • Fluid/Blood Leak1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMay 21, 2026Fluid/Blood Leak

    IT WAS REPORTED THAT A PATIENT ARRIVED AT THE PEDIATRIC EMERGENCY DEPARTMENT AT APPROXIMATELY 2030 WITH LEAKAGE OBSERVED FROM THE PORT TUBING WHILE A HOME BLINATUMOMAB INFUSION WAS RUNNING. THE LEAKAGE WAS IDENTIFIED AT THE BOTTOM OF THE PORT NEEDLE LINE BEFORE CONNECTION TO THE CHEMOTHERAPY ADAPTER, AND THE INFUSION WAS CLOSELY MONITORED AND SUBSEQUENTLY PAUSED AT APPROXIMATELY 2125 FOR PORT REACCESS. BLOOD RETURN WAS VERIFIED, AND BLINATUMOMAB WAS RESTARTED AT 2145 AT A RATE OF 5 ML PER HOUR BY S. MORRIS, RN, AND D. HOPKINS, RN. THE LEAKING PORT NEEDLE HAD BEEN PLACED AT THE OUTPATIENT CLINIC ON 20-APR-26, AND THE CLINIC NEEDLE WAS RETAINED WITH THIS REPORT. THERE WAS A PATIENT INVOLVEMENT WITH NO HARM.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25243173 ↗
  • MalfunctionMay 5, 2021Difficult to Remove; Difficult to Remove

    IT WAS REPORTED THAT WHILE A NURSE TRIED TO REMOVE GRIPPER MICRO TO REMOVE NEEDLE AFTER PORT ACCESS BUT WAS UNABLE TO DO SO. A SECOND NURSE ATTEMPTED WITHOUT SUCCESS SO THE LINE WAS REMOVED AND A NEW NEEDLE USED TO ACCESS WITHOUT ISSUES. TRIED TO PULL BACK TO RELEASE GRIPPER AFTER IT WAS REMOVED FROM PATIENT BUT STILL WAS UNSUCCESSFUL. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11781488 ↗

Other Set, administration, intravascular devices

All Set, administration, intravascular devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page